222 related articles for article (PubMed ID: 36439649)
1. Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop.
Navar AM; Fine LJ; Ambrosius WT; Brown A; Douglas PS; Johnson K; Khera AV; Lloyd-Jones D; Michos ED; Mujahid M; Muñoz D; Nasir K; Redmond N; Ridker PM; Robinson J; Schopfer D; Tate DF; Lewis CE
Am J Prev Cardiol; 2022 Dec; 12():100430. PubMed ID: 36439649
[TBL] [Abstract][Full Text] [Related]
2. Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group.
Gooding HC; Gidding SS; Moran AE; Redmond N; Allen NB; Bacha F; Burns TL; Catov JM; Grandner MA; Harris KM; Johnson HM; Kiernan M; Lewis TT; Matthews KA; Monaghan M; Robinson JG; Tate D; Bibbins-Domingo K; Spring B
J Am Heart Assoc; 2020 Oct; 9(19):e016115. PubMed ID: 32993438
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop.
Greenland P; Michos ED; Redmond N; Fine LJ; Alexander KP; Ambrosius WT; Bibbins-Domingo K; Blaha MJ; Blankstein R; Fortmann SP; Khera A; Lloyd-Jones DM; Maron DJ; Min JK; Muhlestein JB; Nasir K; Sterling MR; Thanassoulis G
JACC Cardiovasc Imaging; 2021 Jul; 14(7):1454-1465. PubMed ID: 32950442
[TBL] [Abstract][Full Text] [Related]
5. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Barnard S; Perel P; Free C
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
[TBL] [Abstract][Full Text] [Related]
6. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
[TBL] [Abstract][Full Text] [Related]
7. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
[TBL] [Abstract][Full Text] [Related]
8. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.
Uthman OA; Hartley L; Rees K; Taylor F; Ebrahim S; Clarke A
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011163. PubMed ID: 26272648
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop.
Schwartz JB; Schmader KE; Hanlon JT; Abernethy DR; Gray S; Dunbar-Jacob J; Holmes HM; Murray MD; Roberts R; Joyner M; Peterson J; Lindeman D; Tai-Seale M; Downey L; Rich MW
J Am Geriatr Soc; 2019 Feb; 67(2):371-380. PubMed ID: 30536694
[TBL] [Abstract][Full Text] [Related]
10. The Miami Heart Study (MiHeart) at Baptist Health South Florida, A prospective study of subclinical cardiovascular disease and emerging cardiovascular risk factors in asymptomatic young and middle-aged adults: The Miami Heart Study: Rationale and Design.
Nasir K; Ziffer JA; Cainzos-Achirica M; Ali SS; Feldman DI; Arias L; Saxena A; Feldman T; Cury R; Budoff MJ; Fialkow J
Am J Prev Cardiol; 2021 Sep; 7():100202. PubMed ID: 34611641
[TBL] [Abstract][Full Text] [Related]
11. Risk scoring for the primary prevention of cardiovascular disease.
Karmali KN; Persell SD; Perel P; Lloyd-Jones DM; Berendsen MA; Huffman MD
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006887. PubMed ID: 28290160
[TBL] [Abstract][Full Text] [Related]
12. Implementing the National Heart, Lung, and Blood Institute's Strategic Vision in the Division of Cardiovascular Sciences.
; Goff DC; Buxton DB; Pearson GD; Wei GS; Gosselin TE; Addou EA; Stoney CM; Desvigne-Nickens P; Srinivas PR; Galis ZS; Pratt C; Kit KBK; Maric-Bilkan C; Nicastro HL; Wong RP; Sachdev V; Chen J; Fine L
Circ Res; 2019 Feb; 124(4):491-497. PubMed ID: 31031412
[TBL] [Abstract][Full Text] [Related]
13. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Garvey WT; Mechanick JI; Brett EM; Garber AJ; Hurley DL; Jastreboff AM; Nadolsky K; Pessah-Pollack R; Plodkowski R;
Endocr Pract; 2016 Jul; 22 Suppl 3():1-203. PubMed ID: 27219496
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
